People: Protalix Biotherapeutics Inc (PLX)
16 Dec 2017
Mr. Tzvi Palash is Chief Operating Officer of Protalix BioTherapeutics Inc. Mr. Maimon joined Protalix Ltd. in October 2006 as its Chief Financial Officer and became our Vice President and Chief Financial Officer in 2006. Prior to joining Protalix, from 2002 to 2006, he served as the Chief Financial Officer of Colbar LifeScience Ltd., or Colbar, a biomaterial company focusing on aesthetics, where he led all of the corporate finance activities, fund raisings and legal aspects of Colbar including the sale of Colbar to Johnson and Johnson (NYSE:JNJ). Mr. Maimon has a B.A. in accounting from the City University of New York and an MBA from Tel Aviv University, and he is a Certified Public Accountant in the United States (New York State) and Israel.
|Total Annual Compensation, USD||283,669|
|Restricted Stock Awards, USD||113,161|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||85,933|
|Fiscal Year Total, USD||482,763|